Lisheng Pharmaceutical: Pre-disclosure announcement on the reduction of shares held by the company’s senior managers
Securities code: 002393 Securities abbreviation: Lisheng Pharmaceutical Announcement number: 2026-031
Tianjin Lisheng Pharmaceutical Co., Ltd.
Pre-disclosure announcement on reduction of shareholdings by senior managers of the company
Ms. Guo Xiaoyan, a senior manager of the Company, guarantees that the information provided to the Company is true, accurate and complete and contains no false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the content of the announcement is consistent with the information provided by the information disclosure obligor.
Special tips:
Guo Xiao, a senior manager of the company who holds 124,320 shares of Tianjin Lisheng Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") (accounting for 0.0402% of the company's total share capital; accounting for 0.0403% of the company's total share capital after excluding the number of shares in the special repurchase account) Ms. Yan plans to reduce the total number of shares held by the company by no more than 22,042 shares through centralized bidding within 3 months after 15 trading days from the date of disclosure of this announcement. The proportion of shares planned to be reduced shall not exceed 0.0072% of the company's total share capital after excluding the number of shares in the special repurchase account.
The company recently received the "Application Form for Share Reduction Plan" issued by Ms. Guo Xiaoyan, a senior manager, and the specific contents are now announced as follows:
1. Basic information on shareholders who intend to reduce their holdings
Accounting companies exclude buybacks
Total share capital of the company. Number of shares in special account. Among them, names held without selling rights. Position held. Number of shares held (shares)
Proportion (%) Proportion of total equity after volume Number of shares (shares)
(%)
Guo Xiaoyan Deputy General Manager 124,320 0.0402 0.0403 22,042
2. Main contents of this shareholding reduction plan
(1) This shareholding reduction plan
Reasons for planned reduction of holdings: personal fund use needs;
Source of shares to be reduced: shares granted by the company’s 2022 restricted stock incentive plan (including the corresponding increase in shares due to the conversion of capital reserve funds into share capital)
The number of shares planned to be reduced and the proportion of the company's total share capital: Ms. Guo Xiaoyan plans to reduce the company's shares by no more than 22,042 shares, and the proportion of shares planned to be reduced shall not exceed 0.0072% of the company's total share capital after excluding the number of shares in the special repurchase account;
Planned reduction method: centralized bidding;
Period of proposed reduction of holdings: within 3 months after 15 trading days from the date of disclosure of this announcement, except for the period during which reduction of holdings is prohibited according to laws and regulations;
The price range of the proposed reduction: determined according to the secondary market price at the time of reduction.
(2) Relevant commitments and implementation status
While serving as a senior executive of the company, the shares transferred each year shall not exceed 25% of the total number of company shares held by him/her. As of the disclosure date of this announcement, Ms. Guo Xiaoyan has strictly complied with the above regulations and has not violated the above regulations.
(3) Other instructions
Ms. Guo Xiaoyan does not fall under the circumstances stipulated in Article 9 of Shenzhen Stock Exchange's "Self-Regulatory Guidelines for Listed Companies No. 18 - Reduction of Shareholdings by Shareholders, Directors and Senior Management Personnel".
3. Related risk warnings
There is uncertainty in the implementation of this share reduction plan. Ms. Guo Xiaoyan will decide whether to implement this share reduction plan based on market conditions, the company’s stock price, etc.
This shareholding reduction plan is a normal shareholding reduction behavior of the company's senior managers. It will not lead to a change in the company's control, nor will it have a significant impact on the company's governance structure and future continued operations.
This shareholding reduction plan complies with the provisions of the Securities Law of the People's Republic of China, the Rules for the Management of the Company's Shares Held by Directors and Senior Managers of Listed Companies and their Changes, the Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 18 - Reduction of Shareholdings by Shareholders, Directors and Senior Managers, and other laws, regulations and normative documents. The company will continue to pay attention to the follow-up implementation of this shareholding reduction plan and urge Ms. Guo Xiaoyan to reduce her shareholding strictly in accordance with relevant laws and regulations and to perform relevant information disclosure obligations in a timely manner.
4. Documents for reference
"Application Form for Share Reduction Plan" issued by Ms. Guo Xiaoyan, senior manager of the company.
Announcement is hereby made.
Board of Directors of Tianjin Lisheng Pharmaceutical Co., Ltd.
May 08, 2026